Company news
Osteopore Ltd. news in 2024
Osteopore Ltd.'s news releases, calls and decks from 2024, newest first.
OSX enters agreement to issue redeemable convertible notes
December 24, 2024
OSX partners scientists to drive regeneration innovation
November 3, 2024
Activities Report September 2024 and Appendix 4C
October 30, 2024
Osteopore to raise A$20m via redeemable convertible note
September 26, 2024
OSX and University of Chile complete bone implant studies
August 21, 2024
Activities Update Qtr Ending June 2024 and Appendix 4C
July 30, 2024
Osteopore strikes Exclusive Distribution with Zimmer Biomet
July 15, 2024
A$18.7m Osteopore, NDCS and A*STAR project hits milestones
June 5, 2024
OSX and SingHealth partner on Global Centre of Excellence
May 13, 2024
Osteopore successfully raises A$2.9m from Entitlement Offer
May 7, 2024
Activities Update Qtr Ending March 2024 and Appendix 4C
April 29, 2024
Response to ASX Price and Volume Query
April 23, 2024
Trading Halt
April 23, 2024
Pause in Trading
April 23, 2024
Reinstatement to Official Quotation
April 16, 2024
Response to ASX Query Letter
April 15, 2024
Osteopore extends Bridging Loan maturity date
April 10, 2024
Replacement Prospectus for Renounceable Rights Issue
April 4, 2024
Update to Replacement Prospectus for Entitlement Offer
April 3, 2024
Osteopore secures Singapore and Vietnam market approvals
March 26, 2024
Prospectus for Renounceable Rights Issue
March 12, 2024
OSX Entitlement Offer to support growth
March 12, 2024
Activities Update Qtr Ending December 2023 and Appendix 4C
January 30, 2024
Notice of General Meeting
January 23, 2024